The pharmaceutical excipients market is expected to reach USD 20.22 billion by 2034, expanding at a compound annual growth rate (CAGR) of 6.6% over the forecast period.
The pharmaceutical excipients market was valued at USD 10.70 billion in 2024 and is projected to grow from USD 11.37 billion in 2025 to USD 20.22 billion by 2034, registering a CAGR of 6.6% during the forecast period (2025–2034). This market includes a wide range of inactive substances incorporated into drug formulations to improve stability, enhance bioavailability, and ensure better patient compliance and acceptability.
Market Definition
The Pharmaceutical Excipients Market refers to the industry focused on the production and supply of inactive substances that are formulated alongside the active pharmaceutical ingredient (API) in medications. Excipients serve various essential roles such as aiding in drug stability, enhancing absorption, improving taste, extending shelf life, and facilitating drug delivery. These substances include binders, fillers, coatings, disintegrants, preservatives, and flavoring agents, and are critical to ensuring the safety, effectiveness, and manufacturability of pharmaceutical products.
Key Report Highlights
· The report highlights the key region that accounts for the highest revenue share in the global Pharmaceutical Excipients market.
· It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.
· The report outlines the dominant segment that holds a major share of the market.
· It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.
· Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.
Market Overview: Key Figures at a Glance
· Market Value in 2025: USD 11.37 billion
· Projected Market Size in 2034: USD 20.22 billion
· Anticipated CAGR 2025-2034:6.6 %
Get access to the full report or request a complimentary sample for in-depth analysis:
https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-excipients-market/request-for-sample
Market Growth Drivers
Rising Demand for Generic and Over-the-Counter (OTC) Drugs
The growing consumption of affordable generics and OTC medications drives the need for high-quality excipients in drug formulation.
Increasing Pharmaceutical R&D Activities
Expanded research into novel drug delivery systems and formulations boosts demand for innovative and multifunctional excipients.
Growing Geriatric Population and Chronic Disease Prevalence
An aging global population and the rise in chronic conditions like diabetes and cardiovascular diseases increase the demand for effective and stable medications.
Advancements in Drug Delivery Technologies
Innovations such as controlled-release, targeted delivery, and orally disintegrating tablets (ODTs) require advanced excipients for performance optimization.
Expansion of Biopharmaceuticals
The rise of biologics and biosimilars necessitates specialized excipients for stability, solubility, and delivery of sensitive molecules.
Market Key Players
The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include
- Archer Daniels Midland Company
- Ashland Global Holdings Inc.
- Associated British Foods plc
- BASF SE
- Colorcon, Inc.
- Croda International Plc
- DFE Pharma
- DuPont de Nemours, Inc.
- Evonik Industries AG
- JRS Pharma
- Kerry Group plc
- MEGGLE GmbH & Co. KG
- Roquette Frères